Premium
Proliferation index as a prognostic marker in hemangiopericytoma of the head and neck
Author(s) -
Kowalski Paul J.,
Paulino Augusto F. G.
Publication year - 2001
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.1065
Subject(s) - mitotic index , hemangiopericytoma , pleomorphism (cytology) , head and neck , proliferation index , pathology , proliferative index , proliferation marker , medicine , immunoperoxidase , stain , biology , immunohistochemistry , staining , mitosis , surgery , immunology , antibody , monoclonal antibody , microbiology and biotechnology
Background Hemangiopericytoma (HPC) of the head and neck is a rare neoplasm whose biologic behavior is difficult to predict by means of conventional histologic parameters. Methods H & E–stained sections from 12 cases of HPC were reviewed. Proliferation index was assessed using an immunoperoxidase stain for MIB‐1 (Ki‐67). Results The study group consisted of 4 adult men, 5 adult women, and 1 infant male. Necrosis, hypercellularity, and pleomorphism were found in 1, 5, and 6 case(s), respectively. The mitotic index per 10 high power fields varied from 0‐1 to 15. Proliferation indices using MIB‐1 ranged from 2.6% to 52.5%. Clinical follow‐up revealed 3 cases with recurrence all possessing proliferation indices of approximately 10%. Conclusions Standard histomorphologic features may be inadequate predictors of clinical outcome. A proliferation index of 10% or greater may indicate a more aggressive subset of HPC of the head and neck. © 2001 John Wiley & Sons, Inc. Head Neck 23: 492–496, 2001.